Snehal Bhoola, MD
Gynecologic Oncology · Savannah, GANPI 1609821016
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,765 of the $9,352 with a category attached, or 72.3%. It is spread thinly across 60 manufacturers, the largest accounting for just 10.8%. Reporting peaked in 2022 at $2,146 and has fallen 58.7% since, to $886 in 2025.
Across 297 payments — averaging $31.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Momentis Surgical Inc.$1K
- Tesaro, Inc.$789
- Intuitive Surgical$725
- AstraZeneca$590
- GSK$405
- Novartis$356
- plus $5K from 54 others
Across 66 payments — averaging $20,562 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.3M
- Tesaro, Inc.$14K
- GSK$157
What the payments were for
- Consulting fees$7508%
- Travel & lodging$95510%
- Food & beverage$6,76572%
- Education$4835%
- Gifts$3994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Anovo Surgical System$955
- ZEJULA$872
- Da Vinci Surgical System$399
- SPY-PHI SYSTEM$139
- LYNPARZA$132
How this compares
$9,352 in reported general payments places this provider in the 75th percentile of 49 gynecologic oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Everolimus | 15 | $48,586 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 90 | $552 |
| Megestrol Acetate | 15 | $411 |
| Ibuprofen | 97 | $399 |
| Letrozole | 29 | $277 |
| Fluconazole | 19 | $166 |
| Oxycodone Hcl | 20 | $144 |
| Tramadol Hcl | 17 | $56 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Savannah
- James BurkeSavannah$276K
- Sarah GillSavannah$9K
- William RichardsSavannah$320
- Benedict BenignoAtlanta$273K
- Sharad GhamandeAugusta$214K
- Ruchi GargNewnan$125K
- Adam PyrzakAtlanta$116K
- Gerald FeuerAtlanta$102K
- Margarett EllisonMoultrie$81K
- Vijaya GalicGainesville$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.